Next Article in Journal
Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation
Previous Article in Journal
Respiratory Physiotherapy in Preterm Neonates with Bronchopulmonary Dysplasia or Respiratory Distress Syndrome: A Comprehensive Review of Clinical Evidence and Therapeutic Implications
Previous Article in Special Issue
Acute Pulmonary Edema in COVID-19: Clinical Predictors, Long-Term Pulmonary Sequelae, and Mortality in a Romanian Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Systematic Review

Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies

by
Ioana-Georgiana Cotet
1,2,
Diana-Maria Mateescu
1,
Dragos-Mihai Gavrilescu
3,*,
Andrei Marginean
4,*,
Stefania Serban
1,
Adrian-Cosmin Ilie
5,
Cristina Guse
1,
Ana-Maria Pah
6,
Marius Badalica-Petrescu
6,
Stela Iurciuc
6,
Maria-Laura Craciun
6,
Adina Avram
6 and
Cristina Tudoran
2,7,8
1
Department of General Medicine, Doctoral School, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania
2
Centre of Molecular Research in Nephrology and Vascular Disease, University of Medicine and Pharmacy “Victor Babes” Timisoara, Eftimie Murgu Square, Nr. 2, 300041 Timisoara, Romania
3
Department of Orthodontics, Dental District, Strada Zăgazului Nr. 3, One Floreasca Vista, Sector 1, 014261 Bucharest, Romania
4
Department of Surgery, “Dr. Victor Popescu” Emergency Military Hospital, 9 Gheorghe Lazăr Street, 300080 Timișoara, Romania
5
Department of Public Health and Sanitary Management, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania
6
Cardiology Department, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania
7
Department VII, Internal Medicine II, Discipline of Cardiology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square, Nr. 2, 300041 Timisoara, Romania
8
County Emergency Hospital “Pius Brinzeu”, L. Rebreanu, Nr. 156, 300723 Timisoara, Romania
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2026, 15(1), 341; https://doi.org/10.3390/jcm15010341
Submission received: 17 November 2025 / Revised: 28 December 2025 / Accepted: 30 December 2025 / Published: 2 January 2026
(This article belongs to the Special Issue Sequelae of COVID-19: Clinical to Prognostic Follow-Up)

Abstract

Background: The COVID-19 pandemic raised uncertainties regarding the safe timing of breast cancer surgery after SARS-CoV-2 infection, and robust prospective evidence has remained limited. Methods: We conducted a systematic review and meta-analysis of prospective cohort studies (2020–2024) investigating postoperative outcomes in breast cancer patients with confirmed SARS-CoV-2 infection ≤90 days before surgery versus contemporaneous non-infected controls treated at the same institutions and in the same period. PROSPERO CRD420251174613. Random-effects models (DerSimonian–Laird with Hartung–Knapp adjustment) were used to pool odds ratios (ORs) and 95% confidence intervals (CIs). Study quality was assessed with the Newcastle–Ottawa Scale, and certainty of evidence was rated using GRADE. Results: Twelve prospective cohort studies, including 7812patients, compared breast cancer surgery after recent confirmed SARS-CoV-2 infection over 90 days with contemporaneous non-infected controls treated at the same centres. Overall, recent infection was associated with higher 30-day postoperative complications (Clavien–Dindo ≥ II)compared to. non-infected patients (OR 2.01, 95% CI 1.44–2.81) and increased venous thromboembolism (3.6%vs. 1.2%; OR 3.12, 95% CI 1.29–7.55). Early surgery 14 days after infection carried the highest risk of complications (OR 4.38, 95 CI 2.31–8.30), whereas operations performed ≥6 weeks yielded outcomes comparable to non-infected controls (OR 1.03, 95 CI 0.81–1.31); 30-day mortality remained very low (0.3). Conclusions: Breast cancer surgery after SARS-CoV-2 infection is associated with excess perioperative risk only when performed within the first two weeks. Delaying surgery to approximately six weeks minimises complications and VTE without compromising short-term safety.
Keywords: breast cancer; COVID-19; SARS-CoV-2; surgery timing; postoperative complications; venous thromboembolism; meta-analysis breast cancer; COVID-19; SARS-CoV-2; surgery timing; postoperative complications; venous thromboembolism; meta-analysis

Share and Cite

MDPI and ACS Style

Cotet, I.-G.; Mateescu, D.-M.; Gavrilescu, D.-M.; Marginean, A.; Serban, S.; Ilie, A.-C.; Guse, C.; Pah, A.-M.; Badalica-Petrescu, M.; Iurciuc, S.; et al. Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies. J. Clin. Med. 2026, 15, 341. https://doi.org/10.3390/jcm15010341

AMA Style

Cotet I-G, Mateescu D-M, Gavrilescu D-M, Marginean A, Serban S, Ilie A-C, Guse C, Pah A-M, Badalica-Petrescu M, Iurciuc S, et al. Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies. Journal of Clinical Medicine. 2026; 15(1):341. https://doi.org/10.3390/jcm15010341

Chicago/Turabian Style

Cotet, Ioana-Georgiana, Diana-Maria Mateescu, Dragos-Mihai Gavrilescu, Andrei Marginean, Stefania Serban, Adrian-Cosmin Ilie, Cristina Guse, Ana-Maria Pah, Marius Badalica-Petrescu, Stela Iurciuc, and et al. 2026. "Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies" Journal of Clinical Medicine 15, no. 1: 341. https://doi.org/10.3390/jcm15010341

APA Style

Cotet, I.-G., Mateescu, D.-M., Gavrilescu, D.-M., Marginean, A., Serban, S., Ilie, A.-C., Guse, C., Pah, A.-M., Badalica-Petrescu, M., Iurciuc, S., Craciun, M.-L., Avram, A., & Tudoran, C. (2026). Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies. Journal of Clinical Medicine, 15(1), 341. https://doi.org/10.3390/jcm15010341

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop